Royal London Asset Management’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$7.34M Sell
94,156
-3,702,094
-98% -$264M 0.12% 191
2016
Q1
$69K Buy
3,796,250
+3,694,229
+3,621% +$201M 0.1% 239
2015
Q4
$6.35M Buy
102,021
+441
+0.4% +$27.8K 0.1% 220
2015
Q3
$6.41M Buy
+101,580
New +$7.25M 0.1% 212
2014
Q4
$60.6K Buy
91,558
+21,214
+30% +$1.37M 0.11% 204
2014
Q3
$4.3M Buy
70,344
+3,981
+6% +$260K 0.11% 206
2014
Q2
$4.31M Sell
66,363
-266
-0.4% -$17.2K 0.1% 224
2014
Q1
$4.28M Sell
66,629
-4,809
-7% -$313K 0.1% 220
2013
Q4
$4.71M Buy
71,438
+605
+0.9% +$35K 0.12% 190
2013
Q3
$4M Hold
70,833
0.11% 214
2013
Q2
$3.23M Buy
+70,833
New +$3.07M 0.09% 247

Other funds holding STJ

Royal London Asset Management's STJ Position: Q2 2016 in Review

Royal London Asset Management reduced its St Jude Medical (STJ) stake by 98% in Q2 2016, selling an estimated $264M and leaving 94,156 shares worth $7.34M. The position accounts for 0.12% of the portfolio, ranked #191.

Royal London Asset Management first reported a position in STJ in Q2 2013 and has held it in 11 quarters since. 615 funds tracked by Wall St. Rank hold STJ as of Q2 2016.

  • Royal London Asset Management held 94,156 shares of St Jude Medical worth $7.34M as of Q2 2016.
  • Royal London Asset Management sold 3,702,094 St Jude Medical shares in Q2 2016, an estimated $264M.
  • St Jude Medical made up 0.12% of Royal London Asset Management's portfolio in Q2 2016, its #191 holding.
  • Royal London Asset Management first reported a position in St Jude Medical in Q2 2013 and has held it in 11 quarters since.
  • 615 funds tracked by Wall St. Rank held St Jude Medical as of Q2 2016.

Based on Royal London Asset Management's 13F filing for Q2 2016, filed 2 Aug 2016.